Gene · 652995
Papers3,485
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,081 to 1,100 of 3,485
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| PI3K/AKT signaling pathway as a critical regulator of Cisplatin response in tumor cells. | Oncol Res | 2021 | 37303943 | PubTator, text mining | PubMed |
| LncRNA MALAT1 promotes breast cancer progression and doxorubicin resistance via regulating miR-570-3p. | Biomed J | 2021 | 35410813 | PubTator, text mining | PubMed |
| Long non-coding RNA HAGLROS facilitates the malignant phenotypes of NSCLC cells via repressing miR-100 and up-regulating SMARCA5. | Biomed J | 2021 | 35307327 | PubTator, text mining | PubMed |
| Transforming Growth Factor-Beta-Regulated LncRNA-MUF Promotes Invasion by Modulating the miR-34a Snail1 Axis in Glioblastoma Multiforme. | Front Oncol | 2021 | 35223453 | PubTator, text mining | PubMed |
| MicroRNAs in Papillary Thyroid Cancer: What Is New in Diagnosis and Treatment. | Front Oncol | 2021 | 35186709 | PubTator, text mining | PubMed |
| Quercetin Arrests in G2 phase, Upregulates INXS LncRNA and Downregulates UCA1 LncRNA in MCF-7 Cells. | Int J Mol Cell Med | 2021 | 35178359 | PubTator, text mining | PubMed |
| MIR100HG Regulates CALD1 Gene Expression by Targeting miR-142-5p to Affect the Progression of Bladder Cancer Cells in vitro, as Revealed by Transcriptome Sequencing. | Front Mol Biosci | 2021 | 35127818 | PubTator, text mining | PubMed |
| p53-Induced LINC00893 Regulates RBFOX2 Stability to Suppress Gastric Cancer Progression. | Front Cell Dev Biol | 2021 | 35127712 | PubTator, text mining | PubMed |
| Relationship between miR-204 and ANGPTL2 expression and diagnosis, pathological stage, and prognosis in patients with colon cancer. | Transl Cancer Res | 2021 | 35116678 | PubTator, text mining | PubMed |
| Long non-coding RNAs regulating multiple proliferative pathways in cancer cell. | Transl Cancer Res | 2021 | 35116622 | PubTator, text mining | PubMed |
| Non-Coding RNAs Regulate the Resistance to Anti-EGFR Therapy in Colorectal Cancer. | Front Oncol | 2021 | 35111681 | PubTator, text mining | PubMed |
| LncRNAs and Rheumatoid Arthritis: From Identifying Mechanisms to Clinical Investigation. | Front Immunol | 2021 | 35087527 | PubTator, text mining | PubMed |
| Emerging Role of Cancer-Associated Fibroblasts-Derived Exosomes in Tumorigenesis. | Front Immunol | 2021 | 35058933 | PubTator, text mining | PubMed |
| Aerial View of the Association Between m6A-Related LncRNAs and Clinicopathological Characteristics of Pancreatic Cancer. | Front Oncol | 2021 | 35047414 | PubTator, text mining | PubMed |
| Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight. | Cell Rep Med | 2021 | 35028613 | PubTator, text mining | PubMed |
| Genomic and Transcriptomic Underpinnings of Melanoma Genesis, Progression, and Metastasis. | Cancers (Basel) | 2021 | 35008286 | PubTator, text mining | PubMed |
| Identification of Novel Tumor Microenvironment-Related Long Noncoding RNAs to Determine the Prognosis and Response to Immunotherapy of Hepatocellular Carcinoma Patients. | Front Mol Biosci | 2021 | 35004851 | PubTator, text mining | PubMed |
| Interplay Among Metabolism, Epigenetic Modifications, and Gene Expression in Cancer. | Front Cell Dev Biol | 2021 | 35004688 | PubTator, text mining | PubMed |
| Editorial: "Non-Coding RNAs in Head and Neck Squamous Cell Carcinoma". | Front Oncol | 2021 | 35004307 | PubTator, text mining | PubMed |
| Long non-coding RNA SND1-IT1 accelerates cell proliferation, invasion and migration via regulating miR-132-3p/SMAD2 axis in retinoblastoma. | Bioengineered | 2021 | 34969359 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/652995/papers?page=55